Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”
Cannabis Law Report
JULY 12, 2019
28) Side effects noted included strangely enough, vomiting and abdominal pain, psychiatric side effects including depression and paranoia, and low blood pressure. September 2004. 32: United States DEA. The fact that this ‘CBD only’ pharmaceutical can cause a positive THC test per the DEA rule 7350 yet has NO WARNING?
73 
Let's personalize your content